CHEMO PHARMA LABORATORIES LTD.
BSE: 506365
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 |
|---|---|---|---|---|---|---|
| INCOME | ||||||
| Revenue | 0.00-100.0% | 0.53 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.00 | 0.00-100.0% | 0.02+112.6% | -0.16-210.1% | 0.15-76.4% | 0.63 |
| Total Income | 0.00-100.0% | 0.53+2439.6% | 0.02+112.6% | -0.16-10.1% | -0.15-123.6% | 0.63 |
| EXPENSES | ||||||
| Expenditure | 0.09-79.8% | 0.43-96.4% | 11.83+59929.4% | 0.02-24.2% | 0.03+23.8% | 0.02 |
| Tax | 0.00 | 0.00 | 0.00-100.0% | 0.16 | — | — |
| PROFIT | ||||||
| PBT | -0.09-188.3% | 0.10+100.8% | -11.81-6322.8% | -0.18-5.0% | -0.17-128.7% | 0.61 |
| Net Profit | -0.09-188.3% | 0.10+100.8% | -11.81-3376.2% | -0.34-94.1% | -0.17-128.7% | 0.61 |
| KEY METRICS | ||||||
| OPM % | — | 18.66% | — | — | — | — |
| NPM % | — | 18.64%+118.64pp | -100.00%-200.00pp | 100.00% | 100.00%+3.33pp | 96.67% |
| EPS | 0.58-10.8% | 0.65-99.2% | 78.70+3382.3% | 2.26+293.2% | -1.17-128.7% | 4.07 |
Corporate Events
Board MeetingCHEMOPH
202629May
Board Meeting
To consider and approve the Audited Financial Results for th…
BSE Filing ↗ Board MeetingCHEMOPH
202521Aug
Board Meeting
consider and approve the request letter dated 11th August, 2…
BSE Filing ↗ Board MeetingCHEMOPH
202512Aug
Board Meeting
To consider and approve the Un-Audited Financial Results for…
BSE Filing ↗ Board MeetingCHEMOPH
202529May
Board Meeting
consider and approve the Audited Financial Results for the q…
BSE Filing ↗ Board MeetingCHEMOPH
202428Oct
Board Meeting
Consider and approve the Un-Audited Financial Statements for…
BSE Filing ↗ Board MeetingCHEMOPH
202429Jul
Board Meeting
Consideration and approval of Un-Audited Financial Results f…
BSE Filing ↗ Board MeetingCHEMOPH
202427May
Board Meeting
Consider and approve Audited Financial Results for the quart…
BSE Filing ↗